Tenofovir Alafenamide Fumarate (TAF) Effect on Residual Intrathecal Immune Activation

计划入组 22 人 · 首次发布于 2016 年 5 月 12 日

The Women TAF-FTC Benchmark Study.

计划入组 54 人

The Women TAF-FTC Benchmark Study

计划入组 54 人 · 首次发布于 2021 年 12 月 2 日

TAF-001

HMB-TAF

FTC-001

Cwm Taf University Health Board

United Kingdom

CWM TAF MORGANNWG UNIVERSITY HEALTH BOARD

United Kingdom

TAS

New Study Shows TAF and Dolutegravir Superior for Second-Line HIV Treatment in Children

Merck's Doravirine/Islatravir Combination Demonstrates Non-Inferiority in Phase 3 HIV Treatment Trials

Bictegravir/FTC/TAF Shows Efficacy in HIV Patients with NRTI Resistance After PI-based Therapy Switch